Document is current

Any future updates will be listed below

The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse

Crossref DOI link: https://doi.org/10.1007/s40319-018-0734-y

Published Online: 2018-07-23

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark